Delhi high court grants stay on Pfizer Corex cough syrup

  • Next hearing plea is slated for March 21
  • Abbot also filed petition in favor of Phensedyl, Hearing on Tuesday 

Delhi High Court granted stay U.S Pharmaceuticals firm pifzer on monday. Court also pending a further hearing on a Government ban on its popular cough syrup Corex. In this metter two lawyers responding the drug maker told reuters.

Absence of Government “show cause notice” in the against on Pfizer Corex Syrup Delhi high court stay on the banned composition. The health ministry banned the combination of chloropheniramine maleate and codeine syrup. In a notice over the weekend saying it could pose a risk of human.

Indian unit Abbot Laboratories also sells the same combination under the brand name Phensedyl. Abbot also filled a petition at the same court, hearing on Tuesday, local television channel said.